Fetal And Neonatal Monitoring Devices Global Market Report 2023 – By Equipment (Fetal, Neonatal), By End User (Hospitals, Diagnostic centers, Pediatric Clinics, Ambulatory Surgical Centers), By Portability (Portable, Non Portable), By Fetal Care Equipment Type (Ultrasound Devices, Fetal Dopplers, Fetal MRI Systems, Fetal Monitors, Fetal Pulse Oximeters), By Neonatal Care Equipment Type (Infant Warmers, Incubators, Convertible Warmers & Incubators, Phototherapy Equipment, Respiratory Devices, Neonatal Monitoring Devices, Diagnostic Imaging Devices) – Market Size, Trends, And Global Forecast 2023-2032

Point-of-care diagnostics devices are designed to aid doctors in performing medical diagnostic testing at or near the point of care, for immediate knowledge on diseases or conditions. These devices are used to test glucose and cholesterol levels, do electrolyte and enzyme analysis, test for drugs of abuse and for infectious diseases, and for pregnancy testing. The main types of point-of-care diagnostic devices and equipment are infectious disease testing kits, cardiometabolic monitoring kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, and others. Pregnancy and fertility test kits are point-of-care diagnostic devices used to test pregnancy and fertility prior to seeing a doctor. The various prescription modes include prescription-based testing devices, and over-the-counter (OTC) testing devices. These are used by end-users such as professional diagnostic centers, hospitals/critical care centres, outpatient healthcare settings, ambulatory care settings, research laboratories, and homes. The global point-of-care diagnostics devices and equipment market is segmented - 1) By Type: Infectious disease testing kits, Cardio metabolic monitoring kits,, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/Cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types 2) By End User: Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home 3) By Prescription Mode: Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices The global point-of-care diagnostics devices and equipment market size will grow from $28.47 billion in 2022 to $32.34 billion in 2023 at a compound annual growth rate (CAGR) of 13.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global point-of-care diagnostics devices and equipment is expected to grow to $48.35 billion in 2027 at a CAGR of 10.6%. An increase in the incidence of target diseases is driving the POC devices and equipment market globally. The rising incidence of chronic diseases, like diabetes, rheumatism, or cancer is increasing steadily worldwide due to poor lifestyle choices and increasing obesity, thus driving the growth of the POC devices and equipment market. For example, according to the Centers for Disease Control and Prevention, In 2020, about 697,000 people in the US died due to heart disease. Major players in the point-of-care diagnostic devices and equipment market report are Abbott, F. Hoffmann-La Roche, Siemens Healthineers, Danaher, Beckman Coulter, Becton Dickinson and Company, QIAGEN N.V., Johnson & Johnson, Alere Inc., and BioMerieux. The POC diagnostics devices and equipment market is expected to slow down due to stringent regulatory policies, which increase the gestational period before the product enters the market. POC devices and equipment manufacturers are required to obtain multiple FDA clearances before launching their product into the market. The entire process of approval consumes a lot of time, thereby restraining the point-of-care diagnostic devices and equipment market growth. Over-the-Counter (OTC) testing is being termed as an important trend driving the growth of the point of care diagnostics market. FDA has approved OTC test kits for cholesterol, fecal occult blood, pregnancy, and HIV/HCV. This method would improve the access to testing and early detection of the disease. These testing kits may generate more revenue than prescription tests over the forecast period due to ease of using the kits, increased home care and self-testing, and a rise in availability and adoption rate. Point of care devices is regulated by the U.S. Food and Drug Administration (FDA) and all the diagnostic laboratory tests are regulated by the clinical laboratory improvement amendments of 1988 (CLIA) that are administered by the Centers for Medicare & Medicaid Services (CMS). As these devices measure the biomarker levels in the body they are classified as class II (requiring 510[k] approval), or III devices (requiring the more tedious premarket approval). On the contrary, to the stringent approvals by FDA, China has a moderately lenient approval mechanism. Therefore, the top companies are using a partnership approach with local vendors and distributors to expand their point-of-care diagnostic devices and equipment market share. North America was the largest region in the point-of-care diagnostic devices and equipment market in 2022. Asia-Pacific was the second-largest region in the global point-of-care diagnostics devices and equipment market share. The regions covered in point-of-care diagnostics devices and equipment market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the point-of-care diagnostic devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. The point-of-care diagnostics market consists of sales of instruments such as pregnancy and fertility testing kits, cholesterol test strips, drug abuse testing kits, and others that are used in point-of-care diagnostics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The point-of-care diagnostics devices and equipment market research report is one of a series of new reports from The Business Research Company that provides point-of-care diagnostics devices and equipment market statistics, including point-of-care diagnostics devices and equipment industry global market size, regional shares, competitors with a point-of-care diagnostics devices and equipment market share, detailed point-of-care diagnostics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care diagnostics devices and equipment industry. This point-of-care diagnostics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Women’s health devices refer to devices that enable them to take control of their health and health-related data with at-home tests and other features. The women’s health devices are used to enhance women's healthcare, including maternal and menstrual health, pelvic and sexual health, fertility, menopause, and contraception, as well as many general health disorders that affect women disproportionately or differently, such as osteoporosis or cardiovascular disease. The main product types of women’s health devices are surgical, diagnostics, contraceptives, labor and delivery, and critical care. A surgical device refers to a specialized device used by surgeon to relieve a medical condition. The applications of women’s health devices include cancer, osteoporosis, infectious disease, uterine fibroids, post-menopausal syndrome, pregnancy, female sterilization, and other applications. The various end-users of women’s health devices include hospitals, obstetrics and gynecology clinics, diagnostic laboratories, ambulatory surgical centers, and other end users. The global women’s health devices market is segmented - 1) By Product: Surgical, Diagnostics, Contraceptives, Labor and Delivery, Critical Care 2) By Type: Devices, Consumables 3) By Application: Cancer, Osteoporosis, Infectious Disease, Uterine Fibroids, Post-menopausal Syndrome, Pregnancy, Female Sterilization, Other Applications 4) By End-user: Hospitals, Obstetrics and Gynaecology Clinics, Diagnostic Laboratories, Ambulatory Surgical Centres, Other End Users The global women’s health devices market size grew from $33.89 billion in 2022 to $36.95 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global women’s health devices is expected to grow to $52.54 billion in 2027 at a CAGR of 9.2%. An increase in government programs aimed at raising awareness about women’s health is contributing to the growth of the women’s health devices market going forward. Government programs aimed at raising awareness about women’s health refer to initiatives and awareness events organized by the government to make the population aware of some societal boosting the public healthcare system's efficiency and effectiveness. These government programs help in creating awareness, which in turn increases the need for women's health devices for easy diagnosis. For instance, in March 2022, according to the Department of Health, Victoria, the Victorian government released its first-ever women’s sexual and reproductive health strategy and priority action plan for women’s sexual and reproductive health. The plan is supported by a $6.6 million investment for action and education to reduce stigma and improve knowledge of sexual and reproductive health and other such issues. Therefore, an increase in government programs aimed at raising awareness about women’s health is expected to boost demand for women’s health devices during the forecast period. Major players in the women’s health devices market are Abbott Laboratories, Koninklijke Philips N.V., CooperSurgical, F. Hoffmann-La Roche, Caldera Medical, GE Healthcare, Carestream Health, Hologic, Medline Industries, Candence Inc., Boston Scientific Corporation, Reckitt Benckiser, BD. Com, Coloplast A/S, and MedGyn Products, Inc. Technological advancement is a key trend gaining popularity in the women’s health devices market. Many companies operating in the women’s health devices sector are looking for new technologies to strengthen their position in the women’s health devices market. For instance, in May 2022, iSono Health, a US-based medical equipment manufacturing company, launched ATUSA, which is the world’s first portable and automated 3D breast ultrasound scanner. This combines a unique 3D ultrasound scanner with artificial intelligence to perform full breast scans and accurately locate breast tumors. It automatically captures the entire breast volume, allowing for unremarkable breast ultrasound imaging at the point of care without the need for a trained ultrasound driver. This launch represents another step forward for the company and the female population. In February 2022, CooperSurgical, a US-based women’s healthcare brand, acquired Cook Medical's reproductive health portfolio for an amount of $875 million. With this acquisition, both companies aim to invest in future growth and new technologies. Cook Medical is a US-based company that manufacturers invasive medical devices for fertility, obstetrics, gynaecology, in vitro fertilization, and assisted reproductive technology. North America was the largest region in the women’s health devices market in 2022. Asia-Pacific is expected to be the fastest-growing region in the women’s health devices market report during the forecast period. The regions covered in the women’s health devices industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the women’s health devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The women’s health devices market consists of sales of contraceptive devices and pharmaceuticals, densitometry, breast implants, obstetrics/gynecology biopsy and imaging. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The women’s health devices market research report is one of a series of new reports from The Business Research Company that provides women’s health devices market statistics, including women’s health devices industry global market size, regional shares, competitors with a women’s health devices market share, detailed women’s health devices market segments, market trends and opportunities, and any further data you may need to thrive in the women’s health devices industry. This women’s health devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Diagnostic imaging equipment allows physicians to view the inside of the human body to help them find any indications of a health condition. The main types of diagnostic imaging equipment are x-ray systems devices and equipment, ultrasound systems devices and equipment, computed tomography (CT) scanners devices and equipment, magnetic resonance imaging systems devices and equipment, cardiovascular monitoring, diagnostic devices and equipment, and nuclear imaging devices, and equipment. Nuclear imaging device and equipment uses a special gamma camera and single-photon emission-computed tomography (SPECT) imaging techniques. The gamma camera records the energy emissions from the radiotracer in the body and converts them into an image. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The global diagnostic imaging equipment market is segmented - 1) By Type: X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables The global diagnostic imaging equipment market size grew from $48.71 billion in 2022 to $51.08 billion in 2023 at a compound annual growth rate (CAGR) of 4.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global diagnostic imaging equipment is expected to grow to $59.1 billion in 2027 at a CAGR of 3.7%. The global increase in chronic diseases is expected to propel the growth of the diagnostic imaging equipment market. A chronic disease is a condition that lasts for a year or longer, necessitates continuous medical care, restricts daily activities, or both, and includes illnesses such as cancer, diabetes, and so on. Imaging techniques in radiology are used to identify a variety of diseases, including diabetes, cancer, and cardiovascular disease. Chronic illnesses that have not yet manifested any symptoms can be found using diagnostic imaging. For instance, according to the International Diabetes Federation (IDF), an umbrella association of 230 national diabetes associations in more than 160 countries, in 2021, 537 million adults aged between 20-79 are living with diabetes (1 in 10 are suffering with diabetes) and this number is expected to reach about 643 million by 2030 and 783 million by 2045. Therefore, a global increase in chronic diseases is expected to drive the growth of the diagnostic imaging equipment market going forward. Major companies in the diagnostic imaging equipment market include Siemens AG, Koninklijke Philips N.V., Fujifilm Corporation, Varian Medical Systems, General Electric Company, Elekta, Carestream Health, Inc., Exact Sciences, Hologic, Inc., and Stryker Corporation. Portable diagnostic equipment is expected to be a fast-growing segment, and competitors are focusing on developing new and innovative portable equipment during the forecast period. Owing to their ease of use and point-of-care applications, their adoption rates are steadily increasing not only for emergency and intensive care units in hospitals, but also as a part of home care organizations. There is also a growing need for portable devices in the emergency care units for easy and quick usage, faster interventions for acute events, and better monitoring. Some of the well-known products include Samsung Electronics’ 32-SLICE CT scanner, Brain Biosciences’ CERPET portable PET scanner, Siemens Healthcare’s Mobilett mira max portable X-ray systems, and Sonosite’s MicroMaxx portable ultrasound system. Western Europe was the largest region in the global diagnostic imaging equipment market in 2022. North America was the second largest region in the global diagnostic imaging equipment market share. Africa. was the smallest region in the global diagnostic imaging equipment market analysis. The regions covered in the diagnostic imaging equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the diagnostic imaging equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The diagnostic imaging equipment market consists of sales of breast imaging devices, brain, neuroimaging devices, 3d medical imaging devices, and other devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The diagnostic imaging equipment market research report is one of a series of new reports from The Business Research Company that provides diagnostic imaging equipment market statistics, including diagnostic imaging equipment industry global market size, regional shares, competitors with a diagnostic imaging equipment market share, detailed diagnostic imaging equipment market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic imaging equipment industry. This diagnostic imaging equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Patient monitoring devices are machines that are used to constantly monitor patients through various vital signs and warning systems to detect and record changes in patient health conditions. The main types of patient monitoring devices market are fetal and neonatal monitoring devices, weight monitoring and body temperature monitoring devices and equipment, vital parameter monitoring devices and equipment, and remote patient monitoring devices and equipment. Fetal and neonatal monitoring devices measure the heart rate and rhythm of the baby (fetus). This lets the healthcare providers see how the baby is doing. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The end-users are hospitals and clinics, diagnostic laboratories, and others. The global patient monitoring devices market is segmented - 1) By Type: Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables Subsegments Covered: Fetal Monitoring Devices, Neonatal Monitoring Devices, Temperature Monitoring Devices, Weight Monitoring Devices, Cardiac Monitoring Devices, Neuromonitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Multiparameter Monitoring Devices, Cardiac Monitors, Respiratory Monitors, Hematological Monitors, Vital Parameter Monitors And Other End Users The global patient monitoring devices market size will grow from $23.46 billion in 2022 to $25.53 billion in 2023 at a compound annual growth rate (CAGR) of 8.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global patient monitoring devices is expected to grow to $34.5 billion in 2027 at a CAGR of 7.8%. The demand for monitoring devices is likely to increase due to the shortage of professionals in the healthcare services industry. According to a report by Mercer, the US requires 2.3 million new healthcare workers by 2025; this includes nurses, physicians, lab technicians, and various other healthcare personnel. This shortage is likely to drive the demand for monitoring systems as these devices allow medical professionals to track multiple patients remotely. This is expected to drive the growth of the patient monitoring devices market in the forecast period. Major companies in the patient monitoring devices market include General Electric Company, Koninklijke Philips N.V., Draegerwerk AG, Cardinal Health, Inc., Masimo, Stryker Corporation, Medtronic Inc., Edwards Lifesciences, Flex Ltd., and Nihon Kohden Corporation. Awareness of diseases is low in many countries across the globe, and this affected the demand for patient monitoring devices in the historic period. For instance, a study conducted by the Indian Council of Medical Research (ICMR) on 213 million people found that only 43.2% are aware of the chronic disease diabetes. This lack of disease awareness limited the diagnosis and treatment pool, thereby restricting market growth for patient monitoring devices. Patient monitoring device manufacturers are offering customized MPMs to cater to the growing patient pool. MPMs monitor different health parameters corresponding to patients’ health conditions. For instance, Infinium Medical’s Omni series monitors are preconfigured with ECG, oxygen saturation, non-invasive blood pressure, and temperature trackers. More advanced health measures such as invasive blood pressure, cardiac output, and anaesthetic agent measurement can be added to this device when needed. Custom MPM is predominantly beneficial for tracking the health status of critically ill patients. Asia-Pacific was the largest region in the global patient monitoring devices market in 2022. North America was the second-largest region in the global patient monitoring devices market share. The regions covered in the patient monitoring devices market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the patient monitoring devices market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The patient monitoring devices market consist of sales of instruments such as blood pressure cuffs, glucometers, pulse oximeter, ECG + stethoscope, wearables (activity trackers and continuous monitoring), and thermometers for patient monitoring. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The patient monitoring devices market research report is one of a series of new reports from The Business Research Company that provides patient monitoring devices market statistics, including patient monitoring devices industry global market size, regional shares, competitors with a patient monitoring devices market share, detailed patient monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the patient monitoring devices industry. This patient monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical equipment calibration services refer to the method of configuring the measurement and the accuracy of the medical device or medical system being used in hospitals. They offer advanced healthcare treatment, including diagnosis, monitoring, and therapy. The medical equipment calibration services are used in hospitals for the maintenance of the medical equipment and to monitor the patients to offer the best services. The main types of services in medical equipment calibration services are in-house, third-party services, and original equipment manufacturer (OEM). An original equipment manufacturer refers to a company that manufactures and sells products or parts of a product that their buyer, or another company, sells to its customers while putting the products under its brand. The different equipment types include fetal monitors, imaging equipment, vital sign monitors, infusion pumps, cardiovascular monitors, ventilators, and others. These are used in hospitals, clinical laboratories, and other end-users. The global medical equipment calibration services market is segmented - 1) By Service: In-house, Third-Party Services, Original Equipment Manufacturer (OEM) 2) By Equipment: Fetal Monitors, Imaging Equipment, Vital Sign Monitors, Infusion Pumps, Cardiovascular Monitors, Ventilators, Other Equipments 3) By End User: Hospitals, Clinical Laboratories, Other End Users The global medical equipment calibration services market size grew from $1.3 billion in 2022 to $1.45 billion in 2023 at a compound annual growth rate (CAGR) of 11.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global medical equipment calibration services is expected to grow to $2.1 billion in 2027 at a CAGR of 9.7%. Rising investment in healthcare infrastructure is expected to propel the growth of the medical equipment calibration service market going forward. The growth in healthcare infrastructure would provide better protection for public health. The medical equipment calibration service helps to ensure that the medical devices available are safe and effective. For instance, according to the Indian Brand Equity Foundation, an Indian-based government ministry, the healthcare market can increase threefold to USD 133.44 billion by 2022. In addition, according to the Centre for Medicaid & Medicare Services, in 2020 U.S. health care spending grew 9.7%, reaching $12,530 per person, or $4.1 trillion. Therefore, rising investment in healthcare infrastructure is driving the growth of the medical equipment calibration services market. Major players in the medical equipment calibration services market are Transcat Inc., Tektronix Inc., Fluke Biomedical, Biomedical Technologies Inc., NS Medical Systems, JM Test Systems, JPen Medical, TAG Medical, Hospicare Equipment Services Corp, Industrial Calibration and Service Co. Inc., RS Calibration, Aussin, ERD LLC, Calibrationhouse, and Autocal Systems. Strategic partnerships and collaborations are a key trend gaining popularity in the medical equipment calibration services market. Companies operating in medical equipment calibration services are undergoing partnerships to strengthen their position in the market. For instance, in April 2022, Ultimo, a US-based company that provides information technology services, partnered with Fluke Biomedical, a US-based medical equipment calibration services manufacturer. This partnership would aim to help healthcare organizations improve efficiency by minimizing the time that technicians spend on manual, paper-based, or repetitive tasks. Furthermore, in March 2020, Tektronix Inc., a US-based manufacturer of medical equipment calibration services, partnered with Coherent Solutions, a US-based software and consulting company. This partnership aims to provide fully-integrated optical communications platforms to new and existing customers in support of the growing global demand for communications across the telecom, datacom, defense/aerospace, and semiconductor markets. In October 2021, Ellab, a Denmark-based developer and supplier of thermal validation and monitoring products, acquired Arena Instrumentation Limited for an undisclosed amount. Through this acquisition, Ellab Group would benefit from Arena's significant knowledge and experience in field calibration, while Arena would get access to Ellab's equipment while utilizing the Ellab brand, client contacts, and infrastructure. Arena Instrumentation Limited is a UK-based company that provides field calibration, instrument commissioning, qualification, and relocation services to the pharmaceutical, biotech, healthcare, and process/manufacturing industries. North America was the largest region in the medical equipment calibration services market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical equipment calibration services market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment calibration services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The medical equipment calibration services market includes revenues earned by entities by electrical safety analyzer calibration, patient simulators, gas flow analyzers, SPO2 & NIBP simulators, EKG electrode impedance, and centrifuges. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The medical equipment calibration services market research report is one of a series of new reports from The Business Research Company that provides medical equipment calibration services market statistics, including medical equipment calibration services industry global market size, regional shares, competitors with a medical equipment calibration services market share, detailed medical equipment calibration services market segments, market trends and opportunities, and any further data you may need to thrive in the medical equipment calibration services industry. This medical equipment calibration services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Home healthcare refers to a set of activities conducted to keep the home healthcare equipment in working condition. Home healthcare is supportive care provided by any professional caregiver in their respective homes where the patient is staying. It is a cost-effective way to deliver quality care at patients’ homes. Home healthcare is used to assist individuals in improving their health function by providing initial treatment and avoiding hospitalization. The main types of equipment in home healthcare are therapeutic, diagnostic, and mobility care. Therapeutic equipment refers to a set of activities conducted to keep it in working condition. The therapeutic equipment includes home respiratory therapy, insulin delivery devices, IV pumps, and others. The different indications include cardiovascular disorders & hypertension, diabetes, respiratory diseases, pregnancy, cancer, wound care, and others, and involve various services such as rehabilitation services, respiratory therapy services, infusion therapy services, and others. The global home healthcare market is segmented - 1) By Equipment: Therapeutic, Diagnostic, Mobility Care 2) By Services: Rehabilitation Services, Respiratory Therapy Services, Infusion Therapy Services, Other Services 3) By Indication: Cardiovascular Disorders & Hypertension, Diabetes, Respiratory Diseases, Pregnancy, Cancer, Wound Care, Other Indications The global home healthcare market size grew from $308 billion in 2022 to $337.18 billion in 2023 at a compound annual growth rate (CAGR) of 9.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the home healthcare market is expected to grow to $479.99 billion in 2027 at a CAGR of 9.2%. The rapid increase in the aging population is significantly driving the growth of the home healthcare market going forward. The increase in the aging population will boost the demand for healthcare as the aged people are more prone to chronic diseases, which is a favorable factor to the home healthcare market, and increases the overall reach of various home health services. This will reduce the unnecessary visits time involved in traveling, hospital admission, and others. For instance, in 2020, according to the United Nations Organisations, a US-based intergovernmental organization, 727 million persons that were aged above 65 years , which will increase to 1.5 billionpeople by 2050. Therefore, the increase in the aging population is driving the growth of the home healthcare market. Major players in the home healthcare market are Fresenius SE & Co. KGaA, F. Hoffmann-La Roche AG, Resmed Inc., American Well, Apple Inc., CVS Health, Humana Inc., LHC Group Inc., Kindred Healthcare, Honor Home Care, Zorgers, Grand World Elder Care, and MediCar. Technological advancements have emerged as a key trend gaining popularity in the home healthcare market. Companies operating in the home healthcare market are adopting new technologies to reinforce their position in the market. For instance, in August 2020, American Homecare Health Services (AHHS), a US-based home health provider, launched telehealth and remote patient monitoring program. The program is launched in partnership with health recovery solutions. The new offering would be used to identify COVID-19 patients through their recorded symptoms and vital signs. In November 2021, Addus Homecare, a US-based company that provides home healthcare services acquired Armada hospice for a deal amount of $29 million. This acquisition helps Addus Homecare in creating multiple markets in various levels of home care services. Armada Hospice is a US-based company that provides hospital and health care services. North America was the largest region in the home healthcare market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the home healthcare market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the home healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The home healthcare market includes revenues earned by entities by physical, occupational, and/or speech therapy, medical social services, care from home health aides, and homemaker or basic assistance care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The home healthcare market research report is one of a series of new reports from The Business Research Company that provides home healthcare market statistics, including home healthcare industry global market size, regional shares, competitors with a home healthcare market share, detailed home healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the home healthcare industry. This home healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global medical equipment is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the growth of the medical equipment market during the forecast period. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical equipment market data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market share. The regions covered in the medical equipment market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in the medical equipment market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified medical equipment market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the medical equipment market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global medical equipment market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, medical equipment market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diagnostic devices (or) equipment market consists of sales of diagnostic equipment and related services by entities (organizations, sole traders, and partnerships) that are used to identify the nature or cause of a certain phenomenon, usually related to a medical condition. Some of the devices include magnetic resonance imaging apparatuses, temperature sensors or pacemakers. The main types of diagnostic devices or equipment are x-rayed systems, ultrasound systems, computed tomography (CT) scanners, magnetic resonance imaging systems, cardiovascular monitoring and diagnostic devices, and nuclear imaging devices. X-rays refer to a type of electromagnetic radiation, just like visible light. The mobility is stationary and mobile and is used in hospitals and diagnostic imaging centers. The global diagnostic equipment market size is expected to grow from $43.81 billion in 2021 to $47.74 billion in 2022 at a compound annual growth rate (CAGR) of 9.0%. The global diagnostic equipment market size is expected to grow to $59.46 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. An increase in the geriatric population is expected to propel the growth of the diagnostic devices market going forward. Older people are likely to suffer from diseases such as diabetes, cancer, and arthritis, among others, which would increase the demand for diagnostic devices. For instance, in 2020, according to the United Nations, a US-based intergovernmental organization, there are approximately 727 million persons are aged 65 years and above worldwide, and expected to reach approximately 1.5 billion persons by 2050. Therefore, the increase in the geriatric population is driving the growth of the diagnostic devices market.  The emergence of routine diagnostic kits is a key trend gaining popularity in the diagnostic devices market. Companies operating in the market are focusing on developing diagnostic kits to gain market coverage. For instance, in March 2022, Mylab Discovery Solutions, an India-based healthcare company, is set to launch an entire range of routine diagnostic kits and devices in conventional and point-of-care formats. Immunology, Biochemistry, and Haematology are the three main market sub-segments represented by the devices and kits included in them.  In July 2021, DiaSorin S.p.A., an Italy-based biotechnology company, acquired Luminex Corporation for a deal amount of $1.8 billion. Through the acquisition, DiaSorin would gain access to Luminex’s multiplexing technology and a portfolio that would strengthen its existing offering while expanding the group's presence in the United States. Further, this agreement would give the life science sector access to Luminex's applications, promoting academic and scientific research, improving collaboration with biopharma businesses, and boosting access to clinical multiplexing assays for upcoming Value-Based Care initiatives. Luminex Corporation is a US-based biotechnology company that manufactures medical diagnostic devices. Major players in the diagnostic equipment market include Philips Healthcare, Hitachi Medical Systems, Fujifilm Holdings, Siemens Healthcare, and GE Healthcare. The regions covered in global diagnostic equipment market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the diagnostic devices or equipment market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The global diagnostic equipment market is segmented - 1) By Type: X-Ray Systems, Ultrasound Systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging Systems, Cardiovascular Monitoring and Diagnostic Devices, and Nuclear Imaging Device 2) By Mobility: Stationary, Mobile 3) By End User: Hospitals, Diagnostic imaging centres